Expression vector of human SIX homeobox 1 (SIX1).
Clone info. | Expression vector of human SIX homeobox 1 (SIX1). |
---|---|
Comment | Expression was confirmed by the depositor with semi-quantitative RT-PCR. |
Vector backbone | pcDNA3.1 (Plasmid) |
Size of vector backbone | 5.4 kb |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cells). |
Gene/insert name | Human SIX1 cDNA |
Depositor|Developer | Sasaki, Hiroki | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature designated by the DEPOSITOR is requested (Nishimura, T, et al., Cancer Sci. 108(2), 216-225, 2017). |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Nishimura, T, et al., Cancer Sci. 108(2), 216-225, 2017)。 |
Catalog # | Resource name | Availability | Shipping form | Fee (non-profit org.) |
---|---|---|---|---|
RDB15335 | pcDNA3.1(+)-SIX1 | Under QC test. Please contact us. | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pcDNA3.1(+)-SIX1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB15335). |
Reference section:
Nishimura, T., Tamaoki, M., Komatsuzaki, R., Oue, N., Taniguchi, H., Komatsu, M., Aoyagi, K., Minashi, K., Chiwaki, F., Shinohara, H., Tachimori, Y., Yasui, W., Muto, M., Yoshida, T., Sakai, Y., Sasaki, H., SIX1 maintains tumor basal cells via transforming growth factor-beta pathway and associates with poor prognosis in esophageal cancer. Cancer Sci. 108 (2): 216-225 (2017). PMID 27987372. [link to RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.
Original, user report and related articles
original | Nishimura, T., SIX1 maintains tumor basal cells via transforming growth factor-beta pathway and associates with poor prognosis in esophageal cancer. Cancer Sci. 108 (2): 216-225 (2017). PMID 27987372. [link to RRC of NBRP] |
---|
Featured content